Navigation Links
Vaccine-Induced Autism Victims in the Thousands Will Finally Get Day in Court

Hearings will begin on June 11th at the U.S. Federal Claims Court to determine if autism is linked to vaccines and their components, including the mercury-based preservative thimerosal. As the Autism Omnibus Proceeding approaches, parents of children diagnosed with autism are calling attention to the conflicts of interest they believe continue to threaten the safety of vaccines.

Among the concerns cited by parents are the close ties between pharmaceutical companies and government regulatory agencies. A July, 2003 UPI investigation revealed the following:

- In two cases in the past four years, vaccines endorsed by the CDC were pulled off the market after a number of infants and adults appear to have suffered devastating side effects, and some died. Critics now worry about a possible link between vaccines and autism, diabetes, asthma and sudden infant death syndrome, among other ailments.

- Members of the CDC's Vaccine Advisory Committee get money from vaccine manufacturers. Relationships have included: sharing a vaccine patent; owning stock in a vaccine company; payments for research; getting money to monitor manufacturer vaccine tests; and funding academic departments.

- The CDC is in the vaccine business. Under a 1980 law, the CDC currently has 28 licensing agreements with companies and one university for vaccines or vaccine-related products. It has eight ongoing projects to collaborate on new vaccines.

Dr. Paul Offit, MD, former chairman of the Advisory Committee on Immunization Practices, which guides vaccine policy decisions at the CDC, embodies the conflicts of interest concern of parents. Dr. Offit has been a long-time defender of injecting mercury, a known neurotoxin, into infants and pregnant women. He is also co-patent holder of the RotaTeq vaccine with pharmaceutical giant Merck, a funder of his research for over a decade. Offit is speaking against parents t oday in support of the vaccine program and pharmaceutical companies at a press conference sponsored by Every Child by Two, a group also funded by pharmaceutical companies and supportive of injecting mercury into infants.

"In my opinion, as glaring as Dr. Offit's conflicts are, what's even more disturbing is that such close ties between vaccine policy decision makers and vaccine manufacturers are routine," said parent and National Autism Association board member Scott Bono. "The bottom line has become vaccine profit rather than vaccine safety. Children diagnosed with autism are suffering the consequences of an unprecedented greed, and their parents aren't going away until the public knows the full details of this man-made disaster."


'"/>




Related medicine news :

1. Antibiotics Helps Autism
2. Latest discovery on Autism
3. Resolving Autism
4. Studying The Causes Of Autism
5. Mercury Pollution Linked To Rise In Autism
6. Autism risks linked to birth factors
7. Autism epidemic is a myth- says a new study
8. Treating Autism More Effectively
9. MMR Vaccination not linked to Autism
10. Autism nothing more than an extreme form of male brain development
11. Brain Enlargement May Be Characteristic of Autism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
Breaking Medicine Technology: